Issue navigation
Volume 39, Issue 9, September 2000
Editorial
Selective Cox‐2 inhibition in man—therapeutic breakthrough or cosmetic advance?
Rheumatology, Volume 39, Issue 9, September 2000, Pages 935–938, https://doi.org/10.1093/rheumatology/39.9.935
Letters to the Editor
Fulminant alveolar haemorrhage in a case of recurrent small vessel vasculitis after renal transplantation
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1042–1044, https://doi.org/10.1093/rheumatology/39.9.1042
Thymoma‐associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1044–1046, https://doi.org/10.1093/rheumatology/39.9.1044
Re: Frequency of sepsis after local corticosteroid injection
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1046–1047, https://doi.org/10.1093/rheumatology/39.9.1046
Strength of methotrexate tablets
Rheumatology, Volume 39, Issue 9, September 2000, Page 1047, https://doi.org/10.1093/rheumatology/39.9.1047
Presence of HIV infection in patients diagnosed with systemic lupus erythematosus
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1047–1048, https://doi.org/10.1093/rheumatology/39.9.1047-a
Rapid response to intravenous corticosteroids in osteitis pubis after Marshall–Marchetti–Krantz urethropexy
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1048–1049, https://doi.org/10.1093/rheumatology/39.9.1048
Obituary
Forthcoming Events
Rheumatology, Volume 39, Issue 9, September 2000, Page 1053, https://doi.org/10.1093/oxfordjournals.rheumatology.a031487
Dr James Sharp, BSc, MD, FRCP, 1919–1999
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1051–1052, https://doi.org/10.1093/rheumatology/39.9.1051
Original Papers
Nitric oxide is a mediator of apoptosis in the rheumatoid joint
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1004–1008, https://doi.org/10.1093/rheumatology/39.9.1004
Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3‐year follow‐up study
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1009–1013, https://doi.org/10.1093/rheumatology/39.9.1009
Outcome of lupus pregnancy: a controlled study
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1014–1019, https://doi.org/10.1093/rheumatology/39.9.1014
Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case–control study
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1020–1026, https://doi.org/10.1093/rheumatology/39.9.1020
The impact of passive coping on rheumatoid arthritis pain
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1027–1030, https://doi.org/10.1093/rheumatology/39.9.1027
Remission and response to early treatment of RA assessed by the Disease Activity Score
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1031–1036, https://doi.org/10.1093/rheumatology/39.9.1031
Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1037–1039, https://doi.org/10.1093/rheumatology/39.9.1037
A diagnostic algorithm for carpal tunnel syndrome based on Bayes's theorem
Rheumatology, Volume 39, Issue 9, September 2000, Pages 1040–1041, https://doi.org/10.1093/rheumatology/39.9.1040
Infrequency of detection of particle‐associated MSRV/HERV‐W RNA in the synovial fluid of patients with rheumatoid arthritis
Rheumatology, Volume 39, Issue 9, September 2000, Pages 950–954, https://doi.org/10.1093/rheumatology/39.9.950
Range of joint motion and disability in patients with osteoarthritis of the knee or hip
Rheumatology, Volume 39, Issue 9, September 2000, Pages 955–961, https://doi.org/10.1093/rheumatology/39.9.955
Significance of anticardiolipin and anti‐β2‐glycoprotein I antibodies in lupus nephritis
Rheumatology, Volume 39, Issue 9, September 2000, Pages 962–968, https://doi.org/10.1093/rheumatology/39.9.962
Long‐term efficacy of azathioprine treatment for proliferative lupus nephritis
Rheumatology, Volume 39, Issue 9, September 2000, Pages 969–974, https://doi.org/10.1093/rheumatology/39.9.969
Meta‐analysis of treatment termination rates among rheumatoid arthritis patients receiving disease‐modifying anti‐rheumatic drugs
Rheumatology, Volume 39, Issue 9, September 2000, Pages 975–981, https://doi.org/10.1093/rheumatology/39.9.975
Osteonecrosis of the knee: differences among idiopathic and secondary types
Rheumatology, Volume 39, Issue 9, September 2000, Pages 982–989, https://doi.org/10.1093/rheumatology/39.9.982
Patient‐initiated hospital follow‐up for rheumatoid arthritis
Rheumatology, Volume 39, Issue 9, September 2000, Pages 990–997, https://doi.org/10.1093/rheumatology/39.9.990
Radiographic damage of large joints in long‐term rheumatoid arthritis and its relation to function
Rheumatology, Volume 39, Issue 9, September 2000, Pages 998–1003, https://doi.org/10.1093/rheumatology/39.9.998
Review
Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years
Rheumatology, Volume 39, Issue 9, September 2000, Pages 939–949, https://doi.org/10.1093/rheumatology/39.9.939
Robin Goodfellow
Robin Goodfellow
Rheumatology, Volume 39, Issue 9, September 2000, Page 1050, https://doi.org/10.1093/rheumatology/39.9.1050
